Symbols / BTMD Stock $2.20 -0.45% biote Corp.

Healthcare • Medical Care Facilities • United States • NGM
BTMD (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Care Facilities
CEO Mr. Bret Christensen
Exch · Country NGM · United States
Market Cap 81.99M
Enterprise Value 161.51M
Income 27.05M
Sales 192.22M
FCF (ttm) 13.27M
Book/sh -1.91
Cash/sh 0.79
Employees 223
Insider 10d —
IPO Apr 28, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 2.97
Forward P/E 3.86
PEG —
P/S 0.43
P/B -1.15
P/C —
EV/EBITDA 4.30
EV/Sales 0.84
Quick Ratio 0.71
Current Ratio 1.22
Debt/Eq —
LT Debt/Eq —
EPS (ttm) 0.74
EPS next Y 0.57
EPS Growth -36.70%
Revenue Growth -6.90%
EPS Gr Q/Q -47.20%
Rev Gr Q/Q —
Earnings (next) 2026-05-06
Earnings (prior) 2026-05-06
ROA 19.06%
ROE —
ROIC —
Gross Margin 71.46%
Oper. Margin 9.40%
Profit Margin 14.07%
Shs Outstand 32.05M
Shs Float 20.26M
Insider Own 9.77%
Instit Own 64.33%
Short Float 7.11%
Short Ratio 4.81
Short Interest 1.69M
52W High 4.75
vs 52W High -53.68%
52W Low 1.27
vs 52W Low 73.23%
Beta 1.71
Impl. Vol. —
Rel Volume 0.68
Avg Volume 243.50K
Volume 166.31K
Target (mean) $2.97
Tgt Median $3.00
Tgt Low $2.00
Tgt High $4.00
# Analysts 5
Recom None
Prev Close $2.21
Price $2.20
Change -0.45%
About

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$2.97
Mean price target
2. Current target
$2.20
Latest analyst target
3. DCF / Fair value
$7.45
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.20
Low
$2.00
High
$4.00
Mean
$2.97

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-16 main Truist Securities Buy → Buy $4
2026-03-12 main B. Riley Securities Neutral → Neutral $2
2026-03-12 main TD Cowen Buy → Buy $3
2025-08-07 down B. Riley Securities Buy → Neutral $4
2025-03-13 main Craig-Hallum Buy → Buy $8
2024-12-16 init Craig-Hallum — → Buy $12
2024-03-13 reit Roth MKM Buy → Buy $9
2024-02-20 init B. Riley Securities — → Buy $9
2024-02-01 init Jefferies — → Buy $7
2024-01-18 main Truist Securities Buy → Buy $9
2024-01-18 main Roth MKM Buy → Buy $7
2023-08-15 main TD Cowen Outperform → Outperform $7
2023-08-14 reit Roth MKM Buy → Buy $12
2023-03-30 main Roth MKM — → Buy $11
2022-09-27 init Truist Securities — → Buy $10
2022-06-24 init Cowen & Co. — → Outperform $11
2022-06-23 init Roth Capital — → Buy $9
News
RSS: Latest BTMD news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-05-13 MORRIS DEBRA L. Director — 11,045 — —
2025-05-13 JACOBY DANA LYNN Director — 12,994 — —
2025-05-07 GUINES, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 447,714 $3.26 $1,461,373
2025-04-30 GUINES, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 1,933 $3.30 $6,371
2025-04-21 GUINES, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 8,801 $3.27 $28,782
2025-04-17 GUINES, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 7,874 $3.29 $25,906
2025-04-09 GUINES, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 48,439 $3.21 $155,388
2025-04-07 GUINES, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 74,440 $3.15 $237,406
2025-03-31 ROYSTONE CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security — 106,000 $3.32 $351,920
2025-03-31 GUINES, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 106,000 $3.32 $351,920
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
192.22
-2.52%
197.19
+6.38%
185.36
+12.37%
164.96
Operating Revenue
192.22
-2.52%
197.19
+6.38%
185.36
+12.37%
164.96
Cost Of Revenue
54.86
-5.63%
58.13
+0.44%
57.88
+6.05%
54.58
Reconciled Cost Of Revenue
54.86
-5.63%
58.13
+0.44%
57.88
+6.05%
54.58
Gross Profit
137.36
-1.22%
139.06
+9.08%
127.48
+15.49%
110.38
Operating Expense
101.81
-5.25%
107.45
+8.73%
98.83
-42.24%
171.10
Selling General And Administration
101.81
-5.25%
107.45
+8.73%
98.83
-42.24%
171.10
Selling And Marketing Expense
—
—
—
4.63
General And Administrative Expense
—
—
—
165.50
Other Gand A
—
—
—
165.50
Other Operating Expenses
—
—
—
0.97
Total Expenses
156.67
-5.38%
165.58
+5.66%
156.70
-30.56%
225.68
Operating Income
35.55
+12.46%
31.61
+10.31%
28.66
+147.19%
-60.72
Total Operating Income As Reported
35.55
+12.46%
31.61
+10.31%
28.66
+147.19%
-60.72
EBITDA
52.22
+234.90%
15.59
+68.84%
9.23
+16.03%
7.96
Normalized EBITDA
39.19
+11.35%
35.20
+11.26%
31.64
+154.08%
-58.49
Reconciled Depreciation
3.67
+2.69%
3.57
+19.37%
2.99
+36.15%
2.20
EBIT
48.55
+303.97%
12.02
+92.58%
6.24
+8.35%
5.76
Total Unusual Items
13.02
+166.43%
-19.61
+12.48%
-22.40
-133.71%
66.45
Total Unusual Items Excluding Goodwill
13.02
+166.43%
-19.61
+12.48%
-22.40
-133.71%
66.45
Special Income Charges
13.02
+166.43%
-19.61
-118.08%
-8.99
-114.66%
61.33
Other Special Charges
—
—
—
0.45
Restructuring And Mergern Acquisition
-13.02
-166.43%
19.61
+118.08%
8.99
+114.55%
-61.77
Net Income
27.05
+756.67%
3.16
-4.79%
3.32
+442.21%
-0.97
Pretax Income
37.58
+3599.21%
1.02
+926.02%
-0.12
-107.18%
1.71
Net Non Operating Interest Income Expense
-10.96
+0.36%
-11.00
-72.89%
-6.36
-57.23%
-4.05
Interest Expense Non Operating
10.96
-0.36%
11.00
+72.89%
6.36
+57.23%
4.05
Net Interest Income
-10.96
+0.36%
-11.00
-72.89%
-6.36
-57.23%
-4.05
Interest Expense
10.96
-0.36%
11.00
+72.89%
6.36
+57.23%
4.05
Other Income Expense
12.99
+166.32%
-19.59
+12.59%
-22.42
-133.72%
66.48
Other Non Operating Income Expenses
-0.03
-363.64%
0.01
+168.75%
-0.02
-155.17%
0.03
Gain On Sale Of Security
—
—
-13.41
-361.58%
5.13
Tax Provision
5.99
+517.22%
0.97
-63.83%
2.68
+591.24%
0.39
Tax Rate For Calcs
0.00
-24.29%
0.00
+0.00%
0.00
-7.34%
0.00
Tax Effect Of Unusual Items
2.07
+150.29%
-4.12
+12.48%
-4.70
-131.24%
15.06
Net Income Including Noncontrolling Interests
31.60
+68589.13%
0.05
+101.64%
-2.81
-311.86%
1.32
Net Income From Continuing Operation Net Minority Interest
27.05
+756.67%
3.16
-4.79%
3.32
+442.21%
-0.97
Net Income From Continuing And Discontinued Operation
27.05
+756.67%
3.16
-4.79%
3.32
+442.21%
-0.97
Net Income Continuous Operations
31.60
+68589.13%
0.05
+101.64%
-2.81
-311.86%
1.32
Minority Interests
-4.55
-246.32%
3.11
-49.17%
6.12
+366.94%
-2.29
Normalized Income
16.09
-13.69%
18.64
-11.27%
21.01
+140.13%
-52.36
Net Income Common Stockholders
27.05
+756.67%
3.16
-4.79%
3.32
+442.21%
-0.97
Otherunder Preferred Stock Dividend
—
—
—
—
Diluted EPS
—
0.09
-30.77%
0.13
+208.33%
-0.12
Basic EPS
—
0.09
-30.77%
0.13
+208.33%
-0.12
Basic Average Shares
—
34.27
+33.30%
25.71
+219.00%
8.06
Diluted Average Shares
—
34.27
+33.30%
25.71
+219.00%
8.06
Diluted NI Availto Com Stockholders
27.05
+756.67%
3.16
-4.79%
3.32
+442.21%
-0.97
Average Dilution Earnings
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
107.61
-12.06%
122.37
-21.20%
155.29
+39.10%
111.64
Current Assets
54.67
-19.75%
68.13
-44.31%
122.34
+20.92%
101.18
Cash Cash Equivalents And Short Term Investments
24.12
-38.68%
39.34
-55.80%
89.00
+12.33%
79.23
Cash And Cash Equivalents
24.12
-38.68%
39.34
-55.80%
89.00
+12.33%
79.23
Cash Financial
—
—
—
79.23
Receivables
7.68
-0.32%
7.70
-5.77%
8.17
+17.65%
6.95
Accounts Receivable
6.87
-10.00%
7.63
+12.07%
6.81
-2.00%
6.95
Gross Accounts Receivable
9.96
+4.09%
9.57
+24.44%
7.69
-2.95%
7.92
Allowance For Doubtful Accounts Receivable
-3.09
-59.61%
-1.94
-120.25%
-0.88
+9.75%
-0.97
Taxes Receivable
0.81
+1039.44%
0.07
-94.80%
1.36
0.00
Inventory
19.06
+28.42%
14.85
-14.23%
17.31
+54.76%
11.18
Raw Materials
0.56
-47.10%
1.05
0.00
—
Work In Process
1.52
+416.61%
0.29
0.00
—
Finished Goods
20.14
+32.58%
15.19
-18.25%
18.58
+66.14%
11.18
Prepaid Assets
3.80
-38.04%
6.13
-18.87%
7.55
+97.90%
3.82
Other Current Assets
0.01
-90.99%
0.11
-63.96%
0.31
—
Total Non Current Assets
52.94
-2.40%
54.24
+64.61%
32.95
+214.82%
10.47
Net PPE
13.45
+31.66%
10.22
+230.18%
3.10
-12.96%
3.56
Gross PPE
21.09
+26.89%
16.62
+90.88%
8.71
+4.10%
8.37
Accumulated Depreciation
-7.64
-19.28%
-6.41
-14.09%
-5.61
-16.72%
-4.81
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
2.70
-16.79%
3.25
+72.94%
1.88
-8.53%
2.05
Machinery Furniture Equipment
6.19
+9.59%
5.65
+6.06%
5.33
+0.76%
5.29
Construction In Progress
2.21
-47.80%
4.23
0.00
0.00
Other Properties
1.69
+568.65%
0.25
—
2.05
Leases
8.31
+155.64%
3.25
+115.87%
1.51
+46.50%
1.03
Goodwill And Other Intangible Assets
14.62
-3.85%
15.21
+205.85%
4.97
-1.97%
5.07
Goodwill
5.83
+0.00%
5.83
0.00
—
Other Intangible Assets
8.79
-6.25%
9.38
+88.56%
4.97
-1.97%
5.07
Non Current Deferred Assets
24.79
-13.74%
28.74
+15.50%
24.88
+1253.86%
1.84
Non Current Deferred Taxes Assets
24.79
-13.74%
28.74
+15.50%
24.88
+1253.86%
1.84
Other Non Current Assets
0.07
+0.00%
0.07
—
—
Total Liabilities Net Minority Interest
158.01
-29.64%
224.57
+17.06%
191.84
+12.90%
169.92
Current Liabilities
44.99
-12.66%
51.51
+131.89%
22.21
+18.38%
18.77
Payables And Accrued Expenses
10.82
-5.58%
11.46
+74.07%
6.58
+6.80%
6.17
Payables
6.83
+17.43%
5.81
+39.33%
4.17
-19.18%
5.16
Accounts Payable
6.83
+17.43%
5.81
+39.90%
4.16
+1.05%
4.11
Current Accrued Expenses
4.00
-29.27%
5.65
+134.16%
2.41
+140.48%
1.00
Pensionand Other Post Retirement Benefit Plans Current
5.81
+2.94%
5.64
-6.97%
6.07
+43.76%
4.22
Total Tax Payable
—
0.00
-100.00%
0.02
-98.38%
1.05
Income Tax Payable
—
0.00
-100.00%
0.02
-98.38%
1.05
Current Debt And Capital Lease Obligation
6.84
+1.02%
6.77
+3.23%
6.56
+2.28%
6.42
Current Debt
6.25
+0.00%
6.25
+0.00%
6.25
+0.00%
6.25
Other Current Borrowings
6.25
+0.00%
6.25
+0.00%
6.25
+0.00%
6.25
Current Capital Lease Obligation
0.59
+13.19%
0.52
+68.17%
0.31
+88.48%
0.17
Current Deferred Liabilities
3.02
+1.89%
2.96
-1.37%
3.00
+52.77%
1.97
Current Deferred Revenue
3.02
+1.89%
2.96
-1.37%
3.00
+52.77%
1.97
Other Current Liabilities
18.50
-25.02%
24.67
—
—
Total Non Current Liabilities Net Minority Interest
113.02
-34.69%
173.06
+2.02%
169.63
+12.22%
151.15
Long Term Debt And Capital Lease Obligation
103.08
-0.97%
104.09
-3.90%
108.31
-5.00%
114.01
Long Term Debt
100.78
-0.41%
101.20
-5.09%
106.63
-4.87%
112.09
Long Term Capital Lease Obligation
2.30
-20.48%
2.89
+72.02%
1.68
-12.82%
1.93
Non Current Deferred Liabilities
1.10
-29.36%
1.55
+17.47%
1.32
+42.76%
0.93
Non Current Deferred Revenue
1.10
-29.36%
1.55
+17.47%
1.32
+42.76%
0.93
Other Non Current Liabilities
8.84
-86.88%
67.41
+12.37%
59.99
+86.84%
32.11
Stockholders Equity
-58.54
+44.74%
-105.93
-260.34%
-29.40
+33.88%
-44.46
Common Stock Equity
-58.54
+44.74%
-105.93
-260.34%
-29.40
+33.88%
-44.46
Capital Stock
0.00
+0.00%
0.00
-33.33%
0.01
+0.00%
0.01
Common Stock
0.00
+0.00%
0.00
-33.33%
0.01
+0.00%
0.01
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
32.30
-2.34%
33.07
-7.73%
35.84
+218.80%
11.24
Ordinary Shares Number
30.71
-2.45%
31.49
-8.08%
34.25
+254.77%
9.66
Treasury Shares Number
1.59
+0.00%
1.59
+0.00%
1.59
+0.00%
1.59
Additional Paid In Capital
0.00
0.00
0.00
0.00
Retained Earnings
-49.55
+50.60%
-100.30
-241.25%
-29.39
+33.89%
-44.46
Gains Losses Not Affecting Retained Earnings
-0.03
+17.14%
-0.04
-191.67%
-0.01
-140.00%
-0.01
Treasury Stock
8.96
+60.09%
5.60
0.00
—
Minority Interest
8.14
+118.40%
3.73
+152.15%
-7.15
+48.25%
-13.81
Other Equity Adjustments
-0.03
+17.14%
-0.04
-191.67%
-0.01
-140.00%
-0.01
Total Equity Gross Minority Interest
-50.40
+50.69%
-102.20
-179.65%
-36.55
+37.29%
-58.27
Total Capitalization
42.24
+993.28%
-4.73
-106.12%
77.23
+14.20%
67.63
Working Capital
9.68
-41.74%
16.61
-83.41%
100.13
+21.50%
82.41
Invested Capital
48.49
+3088.23%
1.52
-98.18%
83.48
+13.00%
73.88
Total Debt
109.92
-0.85%
110.86
-3.49%
114.87
-4.61%
120.43
Net Debt
82.91
+21.73%
68.11
+185.23%
23.88
-38.94%
39.10
Capital Lease Obligations
2.89
-15.32%
3.41
+71.42%
1.99
-4.83%
2.09
Net Tangible Assets
-73.16
+39.60%
-121.14
-252.45%
-34.37
+30.61%
-49.53
Tangible Book Value
-73.16
+39.60%
-121.14
-252.45%
-34.37
+30.61%
-49.53
Current Notes Payable
—
—
—
6.25
Derivative Product Liabilities
—
—
0.00
-100.00%
4.10
Interest Payable
—
—
—
0.00
Inventories Adjustments Allowances
-3.15
-86.57%
-1.69
-32.86%
-1.27
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
35.19
-22.21%
45.24
+68.30%
26.88
+393.58%
-9.16
Cash Flow From Continuing Operating Activities
35.19
-22.21%
45.24
+68.30%
26.88
+393.58%
-9.16
Net Income From Continuing Operations
31.60
+68589.13%
0.05
+101.64%
-2.81
-311.86%
1.32
Depreciation Amortization Depletion
3.67
+2.69%
3.57
+19.37%
2.99
+36.15%
2.20
Depreciation And Amortization
3.67
+2.69%
3.57
+19.37%
2.99
+36.15%
2.20
Other Non Cash Items
-8.55
-135.85%
23.86
+107.79%
11.48
+121.42%
-53.61
Stock Based Compensation
8.92
+2.13%
8.73
-3.56%
9.06
-88.98%
82.18
Provisionand Write Offof Assets
2.02
+302.19%
0.50
+2034.62%
-0.03
-118.57%
0.14
Asset Impairment Charge
1.72
+15.50%
1.49
+52.66%
0.98
+729.68%
-0.15
Deferred Tax
3.98
+237.16%
-2.90
-501.94%
0.72
+197.04%
-0.74
Deferred Income Tax
3.98
+237.16%
-2.90
-501.94%
0.72
+197.04%
-0.74
Operating Gains Losses
—
—
13.41
+386.44%
-4.68
Gain Loss On Investment Securities
—
—
13.41
+361.58%
-5.13
Change In Working Capital
-8.16
-182.13%
9.93
+211.28%
-8.93
+75.07%
-35.81
Change In Receivables
-0.96
+57.74%
-2.27
-348.91%
-0.51
+67.67%
-1.56
Changes In Account Receivables
-0.96
+57.74%
-2.27
-348.91%
-0.51
+67.67%
-1.56
Change In Inventory
-6.24
-268.07%
3.71
+160.91%
-6.10
-257.03%
-1.71
Change In Payables And Accrued Expense
-1.73
-128.01%
6.18
+200.15%
2.06
+106.76%
-30.43
Change In Accrued Expense
-2.74
-159.22%
4.63
+108.37%
2.22
+107.21%
-30.84
Change In Payable
1.01
-34.43%
1.54
+1036.36%
-0.17
-139.66%
0.42
Change In Account Payable
1.01
-34.43%
1.54
+1036.36%
-0.17
-139.66%
0.42
Change In Other Working Capital
-0.40
-310.53%
0.19
-86.74%
1.43
+273.18%
0.38
Change In Other Current Assets
1.69
-41.22%
2.88
+153.19%
-5.42
-137.22%
-2.28
Change In Other Current Liabilities
-0.52
+31.36%
-0.76
-91.94%
-0.40
-81.28%
-0.22
Investing Cash Flow
-6.86
+63.49%
-18.80
-592.89%
-2.71
-47.61%
-1.84
Cash Flow From Continuing Investing Activities
-6.86
+63.49%
-18.80
-592.89%
-2.71
-47.61%
-1.84
Net PPE Purchase And Sale
-5.01
+22.01%
-6.43
-1691.09%
-0.36
-7.81%
-0.33
Purchase Of PPE
-5.01
+22.01%
-6.43
-1691.09%
-0.36
-7.81%
-0.33
Capital Expenditure
-6.86
+1.32%
-6.96
-156.40%
-2.71
-47.61%
-1.84
Capital Expenditure Reported
-1.85
-251.52%
-0.53
+77.66%
-2.35
-56.41%
-1.50
Net Business Purchase And Sale
0.00
+100.00%
-11.84
0.00
—
Purchase Of Business
0.00
+100.00%
-11.84
0.00
—
Net Intangibles Purchase And Sale
—
—
—
—
Purchase Of Intangibles
—
—
—
—
Financing Cash Flow
-43.55
+42.75%
-76.08
-429.09%
-14.38
-122.66%
63.46
Cash Flow From Continuing Financing Activities
-43.55
+42.75%
-76.08
-429.09%
-14.38
-122.66%
63.46
Net Issuance Payments Of Debt
-1.25
+80.00%
-6.25
+0.00%
-6.25
-107.41%
84.38
Issuance Of Debt
5.00
0.00
0.00
-100.00%
125.00
Repayment Of Debt
-6.25
+0.00%
-6.25
+0.00%
-6.25
+84.62%
-40.62
Long Term Debt Issuance
5.00
0.00
0.00
-100.00%
125.00
Long Term Debt Payments
-6.25
+0.00%
-6.25
+0.00%
-6.25
+84.62%
-40.62
Net Long Term Debt Issuance
-1.25
+80.00%
-6.25
+0.00%
-6.25
-107.41%
84.38
Short Term Debt Issuance
—
—
—
—
Short Term Debt Payments
—
—
—
—
Net Short Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
-3.22
+39.38%
-5.32
-3792.36%
0.14
+700.00%
0.02
Common Stock Payments
-3.37
+39.90%
-5.60
0.00
+100.00%
-0.42
Common Stock Dividend Paid
—
—
—
-12.89
Cash Dividends Paid
-1.73
+63.60%
-4.74
+45.43%
-8.69
+32.53%
-12.89
Repurchase Of Capital Stock
-3.37
+39.90%
-5.60
0.00
+100.00%
-0.42
Proceeds From Stock Option Exercised
0.23
-90.54%
2.39
+469.05%
0.42
+105.79%
-7.25
Net Other Financing Charges
-37.58
+39.54%
-62.16
—
-0.80
Changes In Cash
-15.22
+69.33%
-49.64
-607.03%
9.79
-81.34%
52.47
Effect Of Exchange Rate Changes
0.01
+127.27%
-0.02
-15.79%
-0.02
0.00
Beginning Cash Position
39.34
-55.80%
89.00
+12.33%
79.23
+196.01%
26.77
End Cash Position
24.12
-38.68%
39.34
-55.80%
89.00
+12.33%
79.23
Free Cash Flow
28.33
-26.01%
38.29
+58.41%
24.17
+319.83%
-10.99
Interest Paid Supplemental Data
7.88
-17.39%
9.54
+0.62%
9.48
+114.10%
4.43
Income Tax Paid Supplemental Data
2.75
+6.13%
2.59
-41.41%
4.43
+1469.50%
0.28
Common Stock Issuance
0.14
-49.65%
0.28
+95.83%
0.14
-67.42%
0.44
Issuance Of Capital Stock
0.14
-49.65%
0.28
+95.83%
0.14
-67.42%
0.44
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category